About the Lung & Thoracic Oncology Session
Lung and thoracic malignancies remain major areas of cancer research and clinical innovation. This session covers advances in the biology, diagnosis, staging, treatment, and management of lung cancer and other thoracic tumors, with emphasis on targeted therapy, immunotherapy, molecular testing, and multidisciplinary care.
Abstract Scope and Participation
Submissions may address non-small cell lung cancer, small cell lung cancer, mesothelioma, thoracic tumors, molecular alterations, screening, imaging, surgery, radiation, targeted therapies, immunotherapy, and treatment resistance. Thoracic oncologists, pulmonologists, surgeons, researchers, radiologists, and multidisciplinary professionals are welcome.
Topics Covered in Lung & Thoracic Oncology
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Targeted Lung Therapies
Thoracic Immunotherapy
Mesothelioma
Lung Cancer Screening
Related Scientific Sessions at CIOC 2027
Why Attend the Lung & Thoracic Oncology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Lung & Thoracic Oncology work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Lung & Thoracic Oncology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Lung & Thoracic Oncology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Lung & Thoracic Oncology Conference 2027 — FAQs
What is the Lung & Thoracic Oncology track at CIOC 2027?
The Lung & Thoracic Oncology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Lung & Thoracic Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Lung & Thoracic Oncology sessions?
Cancer researchers and clinicians, educators and students with an interest in Lung & Thoracic Oncology are all welcome — whether presenting or attending.
Can I present my research in the Lung & Thoracic Oncology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Lung & Thoracic Oncology sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Lung & Thoracic Oncology track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.